Skip to main content

Charles Yoon Kim

Professor of Radiology
Radiology, Interventional Radiology
Box 3808 Med Ctr, Durham, NC 27710
Department of Radiology, Durham, NC 27710

Overview


Minimally invasive treatments of liver, kidney, and other solid tumors including microwave ablation, cryoablation, embolization, and radioembolization, treatment of benign tumors such as osteoid osteoma and desmoid tumors with cryoablation, endovascular strategies for treatment of complex central venous occlusions, salvage therapy for failing hemodialysis access,  complex enteral feeding access.

Current Appointments & Affiliations


Professor of Radiology · 2021 - Present Radiology, Interventional Radiology, Radiology
Chief, Vascular Interventional Radiology · 2017 - Present Radiology, Clinical Science Departments
Member of the Duke Cancer Institute · 2017 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published December 31, 2019
Interventional Radiologist, Vascular Surgeon Collaborate to Resolve Complex Venous Occlusions
Published November 25, 2019
Incubation Awards to Assist Seven Innovative Research Projects Move Toward the Market

View All News

Recent Publications


Provocative Mesenteric Angiography for Obscure Gastrointestinal Hemorrhage: An Update on Outcomes, Safety, and Predictors of Success.

Journal Article J Vasc Interv Radiol · July 3, 2025 PURPOSE: The purpose of this study was to confirm the safety and modest effectiveness of provocative mesenteric angiography (PMA) in patients with occult gastrointestinal hemorrhage and to identify predictors of success. MATERIALS AND METHODS: Retrospectiv ... Full text Link to item Cite

Impact of Antiplatelet and Anticoagulation Therapy on Hemodialysis Reliable Outflow Graft Patency.

Journal Article Ann Vasc Surg · June 3, 2025 BACKGROUND: The Hemodialysis Reliable Outflow (HeRO) graft combines an arteriovenous graft with a central venous stent, allowing for hemodialysis access in patients with end-stage renal disease limited by central venous stenosis. The impact of anticoagulat ... Full text Link to item Cite

Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians.

Journal Article CA Cancer J Clin · May 20, 2025 Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer-related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer-reviewed guidelines regarding systemi ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


Columbia University · 2001 M.D.